Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer
Clinical trial NCT04194684 · UNKNOWN
Trial details
- NCT number
- NCT04194684
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-28
- Primary completion
- 2022-12-28
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.